3 antibody, an anti glypican 3 antibody having a modulated plasma half life and a pharmaceutical composition comprising the antibody as an active ingredient, as well as {HEAD ~ a method} of preparing {TAIL ~ the anti glypican 3 antibody} and the pharmaceutical composition 
3 antibody , an anti glypican 3 antibody having a modulated plasma half life and a pharmaceutical composition comprising the antibody as an active ingredient , as well as { HEAD ~ a method } of preparing { TAIL ~ the anti glypican 3 antibody } and the pharmaceutical composition
OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD HEAD REL REL TAIL TAIL TAIL TAIL TAIL TAIL TAIL TAIL TAIL OTH OTH OTH OTH